Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 35.95%-123.18M | ---- | -4.49%-192.32M | ---- | -57.57%-184.06M | ---- | -135.97%-116.81M | ---- | -65.26%-49.5M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 49.76%-641K | ---- | 19.55%-1.28M | ---- | -207.96%-1.59M | ---- | 25.25%-515K | ---- | 48.08%-689K | ---- |
| Attributable subsidiary (profit) loss | -37.21%27K | ---- | -48.81%43K | ---- | 37.70%84K | ---- | -50.81%61K | ---- | 214.81%124K | ---- |
| Impairment and provisions: | -61.70%8.67M | ---- | -69.59%22.62M | ---- | 389.54%74.4M | ---- | -302.30%-25.7M | ---- | -8.09%-6.39M | ---- |
| -Impairment of property, plant and equipment (reversal) | -62.82%8.32M | ---- | --22.38M | ---- | ---- | ---- | ---- | ---- | --8.13M | ---- |
| -Impairmen of inventory (reversal) | 40.41%344K | ---- | 169.80%245K | ---- | 56.88%-351K | ---- | 76.39%-814K | ---- | -211.73%-3.45M | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | -738.10%-1.06M | ---- | -107.75%-126K | ---- | 3,971.43%1.63M | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | 406.22%75.81M | ---- | -95.01%-24.76M | ---- | -41.80%-12.69M | ---- |
| Revaluation surplus: | -153.69%-35.35M | ---- | 446.45%65.85M | ---- | 270.77%12.05M | ---- | 112.20%3.25M | ---- | 56.41%-26.63M | ---- |
| -Other fair value changes | -153.69%-35.35M | ---- | 446.45%65.85M | ---- | 270.77%12.05M | ---- | 112.20%3.25M | ---- | 56.41%-26.63M | ---- |
| Asset sale loss (gain): | ---15K | ---- | ---- | ---- | ---80K | ---- | ---- | ---- | --1K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---15K | ---- | ---- | ---- | ---80K | ---- | ---- | ---- | --1K | ---- |
| Depreciation and amortization: | -34.89%12.22M | ---- | -62.54%18.76M | ---- | -53.13%50.08M | ---- | -3.57%106.85M | ---- | -4.91%110.8M | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | -80.93%7.16M | ---- | 274.51%37.53M | ---- | -2.29%10.02M | ---- |
| -Other depreciation and amortization | -15.81%6.26M | ---- | -62.70%7.44M | ---- | -53.91%19.95M | ---- | -41.82%43.28M | ---- | -11.05%74.39M | ---- |
| Financial expense | -4.91%23.42M | ---- | 3.48%24.63M | ---- | 39.15%23.81M | ---- | 5.79%17.11M | ---- | -8.36%16.17M | ---- |
| Special items | 198.68%82.34M | ---- | --27.57M | ---- | ---- | ---- | ---- | ---- | --302K | ---- |
| Operating profit before the change of operating capital | 4.72%-32.51M | ---- | -34.85%-34.12M | ---- | -60.64%-25.3M | ---- | -135.64%-15.75M | ---- | 23.52%44.19M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -46.26%1.99M | ---- | -19.89%3.71M | ---- | -77.39%4.63M | ---- | 549.11%20.46M | ---- | -26.14%-4.56M | ---- |
| Accounts receivable (increase)decrease | -106.85%-908K | ---- | -23.87%13.26M | ---- | 116.83%17.42M | ---- | 129.06%8.03M | ---- | -372.64%-27.65M | ---- |
| Accounts payable increase (decrease) | 119.80%1.17M | ---- | -287.84%-5.89M | ---- | 109.04%3.13M | ---- | -342.59%-34.66M | ---- | -146.17%-7.83M | ---- |
| prepayments (increase)decrease | -386.43%-1.65M | ---- | -122.63%-339K | ---- | 673.95%1.5M | ---- | 83.90%-261K | ---- | 76.89%-1.62M | ---- |
| Special items for working capital changes | 50.39%-128K | ---- | 75.31%-258K | ---- | -104,600.00%-1.05M | ---- | -99.01%1K | ---- | -75.95%101K | ---- |
| Cash from business operations | -35.55%-32.04M | ---- | -7,284.50%-23.64M | ---- | 101.48%329K | ---- | -941.58%-22.18M | ---- | -95.00%2.64M | ---- |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | -30.03%466K | ---- | -69.55%666K | ---- | 133.29%2.19M | ---- |
| Other taxs | 1,694.41%5.78M | ---- | 7.33%322K | ---- | 1,211.11%300K | ---- | 98.53%-27K | ---- | 76.87%-1.84M | ---- |
| Interest received - operating | -48.24%616K | ---- | -14.39%1.19M | ---- | 325.08%1.39M | ---- | 528.85%327K | ---- | -80.30%52K | ---- |
| Special items of business | ---- | 21.46%-9.35M | ---- | -220.20%-11.91M | ---- | 574.29%9.91M | ---- | -131.47%-2.09M | ---- | -28.06%6.64M |
| Net cash from operations | -15.91%-25.65M | 21.46%-9.35M | -990.34%-22.13M | -220.20%-11.91M | 111.71%2.49M | 574.29%9.91M | -797.96%-21.22M | -131.47%-2.09M | -92.09%3.04M | -28.06%6.64M |
| Cash flow from investment activities | ||||||||||
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---2.46M | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | --32K | ---- | ---- | ---- | --84K | ---- | ---- | ---- | 0.00%6K | ---- |
| Purchase of fixed assets | 35.97%-760K | ---- | -3.22%-1.19M | ---- | 87.63%-1.15M | ---- | 37.65%-9.3M | ---- | -74.34%-14.91M | ---- |
| Purchase of intangible assets | 71.27%-2.33M | ---- | -1.59%-8.13M | ---- | -46.83%-8M | ---- | 7.96%-5.45M | ---- | 73.73%-5.92M | ---- |
| Other items in the investment business | ---99K | 62.62%-2.08M | ---- | -38.23%-5.55M | ---- | -128.32%-4.02M | --24.45M | 252.55%14.19M | ---- | 47.14%-9.3M |
| Net cash from investment operations | 66.05%-3.16M | 62.62%-2.08M | 19.22%-9.31M | -38.23%-5.55M | -218.85%-11.53M | -128.32%-4.02M | 146.58%9.7M | 252.55%14.19M | 7.08%-20.83M | 47.14%-9.3M |
| Net cash before financing | 8.37%-28.81M | 34.55%-11.43M | -247.64%-31.44M | -396.49%-17.46M | 21.49%-9.04M | -51.32%5.89M | 35.24%-11.52M | 554.55%12.1M | -210.96%-17.79M | 68.18%-2.66M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 66.05%20.98M | ---- | -48.55%12.64M | ---- | --24.56M | ---- | ---- | ---- | --156M | ---- |
| Refund | ---- | ---- | ---- | ---- | ---24.96M | ---- | ---- | ---- | -47,520.24%-195.24M | ---- |
| Issuing shares | --33.67M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 19.97%-2.33M | ---- | 72.52%-2.91M | ---- | -283.76%-10.58M | ---- | 72.75%-2.76M | ---- | 25.94%-10.12M | ---- |
| Issuance expenses and redemption of securities expenses | ---2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | 472.30%11.24M | ---- | 1.34%-3.02M | ---- | 0.29%-3.06M | ---- | 65.08%-3.07M | ---- | -12.80%-8.79M |
| Net cash from financing operations | 563.91%48.19M | 472.30%11.24M | 149.42%7.26M | 1.34%-3.02M | -138.36%-14.69M | 0.29%-3.06M | 88.58%-6.16M | 65.08%-3.07M | -175.12%-53.95M | -12.80%-8.79M |
| Effect of rate | 123.61%951K | 515.79%2.84M | -1,606.78%-4.03M | 43.09%-684K | 93.36%-236K | 64.56%-1.2M | -17.33%-3.56M | -83.15%-3.39M | -202.12%-3.03M | 17.58%-1.85M |
| Net Cash | 180.18%19.39M | 99.06%-193K | -1.88%-24.18M | -823.45%-20.48M | -34.23%-23.73M | -68.66%2.83M | 75.35%-17.68M | 178.90%9.03M | -1,902.18%-71.74M | 29.14%-11.45M |
| Begining period cash | -59.11%19.51M | -59.11%19.51M | -33.44%47.71M | -33.44%47.71M | -22.85%71.68M | -22.85%71.68M | -44.59%92.92M | -44.59%92.92M | -0.37%167.68M | -0.37%167.68M |
| Cash at the end | 104.25%39.85M | -16.54%22.16M | -59.11%19.51M | -63.79%26.55M | -33.44%47.71M | -25.62%73.31M | -22.85%71.68M | -36.16%98.56M | -44.59%92.92M | 2.99%154.38M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.